Trial Profile
Outcomes of de novo belatacept versus tacrolimus in kidney recipients of high risk donors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Mycophenolate sodium; Tacrolimus
- Indications Delayed graft function
- Focus Therapeutic Use
- 14 Nov 2016 New trial record